Citadel Advisors’s Genelux GNLX Stock Holding History

Citadel Advisors’s Portfolio GNLX Stock Details GNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$257K	Buy	+85,481	New	+$242K	﹤0.01%	11471
2026 Q1	–	Sell	-19,415	Closed	-$84.6K	–	13449
2025 Q4	$84.6K	Sell	19,415 -14,828	-43%	-$80.1K	﹤0.01%	11758
2025 Q3	$144K	Buy	+34,243	New	+$122K	﹤0.01%	11559
2025 Q2	–	Sell	-57,890	Closed	-$156K	–	13465
2025 Q1	$156K	Buy	57,890 +38,436	+198%	+$144K	﹤0.01%	10813
2024 Q4	$45.9K	Sell	19,454 -39,112	-67%	-$104K	﹤0.01%	12476
2024 Q3	$139K	Buy	58,566 +43,655	+293%	+$96.1K	﹤0.01%	10667
2024 Q2	$29.1K	Sell	14,911 -29,849	-67%	-$101K	﹤0.01%	12304
2024 Q1	$288K	Buy	+44,760	New	+$407K	﹤0.01%	9536
2023 Q2	–	Sell	-10,615	Closed	-$294K	–	14665
2023 Q1	$294K	Buy	+10,615	New	+$172K	﹤0.01%	9411

Other funds holding GNLX

WDC

Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

FLPIM

F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $6.54B AUM

Citadel Advisors's GNLX Position: Q2 2026 in Review

Citadel Advisors opened a new position in Genelux (GNLX) in Q2 2026: 85,481 shares worth $257K. The stake represents ﹤0.01% of the portfolio and ranks #11471 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in GNLX as recently as Q4 2025.

Citadel Advisors first reported a position in GNLX in Q1 2023 and has held it in 9 quarters since. The position peaked at $294K in Q1 2023. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

Citadel Advisors held 85,481 shares of Genelux worth $257K as of Q2 2026.
Genelux was a new Citadel Advisors position in Q2 2026.
Genelux made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11471 holding.
Citadel Advisors first reported a position in Genelux in Q1 2023 and has held it in 9 quarters since.
Citadel Advisors's Genelux position peaked at $294K in Q1 2023.
72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.